DAWN – Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, IncDAWN
$12.54Name : Day One Biopharmaceuticals, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $1,264,608,896.00
EPSttm : -0.97
Day One Biopharmaceuticals, Inc
$12.54
1.13%$0.14Float Short %
25.53
Margin Of Safety %
Put/Call OI Ratio
0.55
EPS Next Q Diff
-0.72
EPS Last/This Y
1.56
EPS This/Next Y
-0.31
Price
12.54
Target Price
36.11
Analyst Recom
1.2
Performance Q
-16.46
Relative Volume
1.12
Beta
-1.46
Ticker: DAWN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | DAWN | 12.49 | 0.38 | 1.83 | 10145 |
| 2024-12-20 | DAWN | 12.78 | 0.42 | 0.20 | 10855 |
| 2024-12-23 | DAWN | 12.69 | 0.49 | 0.44 | 7205 |
| 2024-12-24 | DAWN | 12.67 | 0.48 | 0.00 | 7215 |
| 2024-12-26 | DAWN | 12.9 | 0.48 | 0.00 | 7244 |
| 2024-12-27 | DAWN | 12.86 | 0.48 | 0.18 | 7252 |
| 2024-12-30 | DAWN | 12.57 | 0.51 | 4.51 | 7258 |
| 2024-12-31 | DAWN | 12.67 | 0.56 | 0.02 | 7612 |
| 2025-01-02 | DAWN | 12.7 | 0.55 | 0.82 | 7749 |
| 2025-01-03 | DAWN | 12.58 | 0.55 | 0.67 | 7797 |
| 2025-01-06 | DAWN | 12.21 | 0.55 | 0.12 | 7799 |
| 2025-01-07 | DAWN | 12.39 | 0.55 | 0.31 | 7819 |
| 2025-01-08 | DAWN | 12.17 | 0.55 | 1.94 | 7857 |
| 2025-01-09 | DAWN | 12.2 | 0.55 | 2.00 | 7857 |
| 2025-01-10 | DAWN | 11.8 | 0.56 | 0.47 | 7899 |
| 2025-01-13 | DAWN | 11.54 | 0.55 | 0.52 | 8164 |
| 2025-01-14 | DAWN | 11.16 | 0.55 | 0.37 | 8150 |
| 2025-01-15 | DAWN | 11.85 | 0.55 | 0.69 | 8154 |
| 2025-01-16 | DAWN | 12.39 | 0.55 | 1.30 | 8184 |
| 2025-01-17 | DAWN | 12.55 | 0.55 | 0.19 | 9230 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | DAWN | 12.44 | 25.6 | - | -0.81 |
| 2024-12-20 | DAWN | 12.79 | 25.6 | - | -0.81 |
| 2024-12-23 | DAWN | 12.69 | 25.6 | - | -0.81 |
| 2024-12-24 | DAWN | 12.67 | 25.6 | - | -0.81 |
| 2024-12-26 | DAWN | 12.90 | 25.6 | - | -0.81 |
| 2024-12-27 | DAWN | 12.87 | 25.6 | - | -0.81 |
| 2024-12-30 | DAWN | 12.57 | 25.6 | - | -0.81 |
| 2024-12-31 | DAWN | 12.67 | 25.6 | - | -0.81 |
| 2025-01-02 | DAWN | 12.69 | 25.6 | - | -0.81 |
| 2025-01-03 | DAWN | 12.58 | 25.6 | - | -0.81 |
| 2025-01-06 | DAWN | 12.20 | 25.6 | - | -0.81 |
| 2025-01-07 | DAWN | 12.39 | 25.6 | - | -0.81 |
| 2025-01-08 | DAWN | 12.20 | 25.6 | - | -0.81 |
| 2025-01-09 | DAWN | 12.20 | 25.6 | - | -0.81 |
| 2025-01-10 | DAWN | 11.80 | 25.6 | - | -0.81 |
| 2025-01-13 | DAWN | 11.54 | 25.6 | - | -0.81 |
| 2025-01-14 | DAWN | 11.16 | 25.6 | - | -0.81 |
| 2025-01-15 | DAWN | 11.86 | 25.6 | - | -0.81 |
| 2025-01-16 | DAWN | 12.40 | 25.6 | - | -0.81 |
| 2025-01-17 | DAWN | 12.54 | 25.6 | - | -0.81 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | DAWN | -0.59 | 29.36 | 26.83 |
| 2024-12-20 | DAWN | -0.59 | 29.36 | 26.83 |
| 2024-12-23 | DAWN | -0.54 | 29.57 | 26.83 |
| 2024-12-24 | DAWN | -0.54 | 29.57 | 26.83 |
| 2024-12-26 | DAWN | -0.56 | 29.57 | 24.91 |
| 2024-12-27 | DAWN | -0.55 | 29.57 | 24.91 |
| 2024-12-30 | DAWN | -0.56 | 29.48 | 24.91 |
| 2024-12-31 | DAWN | -0.56 | 29.48 | 24.91 |
| 2025-01-02 | DAWN | -0.55 | 29.48 | 24.91 |
| 2025-01-03 | DAWN | -0.55 | 29.48 | 24.91 |
| 2025-01-06 | DAWN | -0.56 | 29.56 | 24.91 |
| 2025-01-07 | DAWN | -0.56 | 29.56 | 24.91 |
| 2025-01-08 | DAWN | -0.55 | 29.56 | 24.91 |
| 2025-01-09 | DAWN | -0.55 | 29.56 | 24.91 |
| 2025-01-10 | DAWN | -0.55 | 29.56 | 24.91 |
| 2025-01-13 | DAWN | -0.55 | 29.59 | 25.53 |
| 2025-01-14 | DAWN | -0.55 | 29.59 | 25.53 |
| 2025-01-15 | DAWN | -0.55 | 29.59 | 25.53 |
| 2025-01-16 | DAWN | -0.55 | 29.59 | 25.53 |
| 2025-01-17 | DAWN | -0.55 | 29.59 | 25.53 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.38
Avg. EPS Est. Current Quarter
-0.48
Avg. EPS Est. Next Quarter
-0.34
Insider Transactions
-0.55
Institutional Transactions
29.59
Beta
-1.46
Average Sales Estimate Current Quarter
26
Average Sales Estimate Next Quarter
32
Fair Value
Quality Score
28
Growth Score
24
Sentiment Score
44
Actual DrawDown %
56.3
Max Drawdown 5-Year %
Target Price
36.11
P/E
Forward P/E
PEG
P/S
12.4
P/B
2.28
P/Free Cash Flow
EPS
-1.01
Average EPS Est. Cur. Y
-0.81
EPS Next Y. (Est.)
-1.12
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-82.68
Relative Volume
1.12
Return on Equity vs Sector %
-34.3
Return on Equity vs Industry %
-21.7
EPS 1 7Days Diff
0.8
EPS 1 30Days Diff
0.87
EBIT Estimation
Day One Biopharmaceuticals, IncSector: Healthcare
Industry: Biotechnology
Employees: 174
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading